SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 1, 2026

RVMD

Revolution Medicines, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $817K total
Actionable Insight • Neutral

Insider sales are immaterial relative to market cap and likely driven by routine portfolio diversification or tax planning. The CFO's $762K sale is a single transaction at a $39.9B market cap, no bearish signal. Monitor for any upcoming data readouts or regulatory catalysts that could drive the stock, but this cluster has no actionable trading edge.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$189.24
T+0 close · Jul 1, 2026 · via day close
Latest settled
+6.61%
T+60 · $201.74
Vs SPY
+3.81%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 2 $189.24entry
  2. T+1 · 4mo ago +0.40%α −0.48% · $189.99
  3. T+5 · 4mo ago −1.25%α −2.61% · $186.88
  4. T+20 · 4mo ago −0.90%α −1.21% · $187.53
  5. T+60 · 7w ago +6.61%α +3.81% · $201.74
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Revolution Medicines sold a total of $817K in stock over a 7-day window. CFO Jack Anders sold $762K (4.6K shares at $167.34) and Director Patel Sushil sold $55K (300 shares at $183.17) after exercising options. The total sales represent ~0.002% of the $39.9B market cap, a trivial amount with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$817.0K
Insiders
2

Key Facts

  • CFO Jack Anders sold $762K worth of RVMD stock on 2026-06-24 at $167.34/share
  • Director Patel Sushil sold $55K worth of RVMD stock on 2026-06-29 at $183.17/share
  • Total insider sales of $817K represent ~0.002% of RVMD's $39.9B market cap
  • Patel Sushil also exercised options for 2,955 shares at $37.54/share on 2026-06-29
  • No open-market insider purchases in the cluster window

Financial Impact

Total insider sales of $817K represent ~0.002% of RVMD's $39.9B market cap, a trivial amount

insider ownership

Risk Factors

  • Insider sales could accelerate if stock continues to appreciate
  • No open-market purchases to signal insider conviction

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
96% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RVMD-1782976983692

US Market Status

Market Closed · Opens Wed (9h 31m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 2, 2026